Platelet Activation in Patients with Atherosclerotic Renal Artery Stenosis Undergoing Stent Revascularization | Zendy

Steven T. Haller | Zendy; Satjit Adlakha | Zendy; Grant W. Reed | Zendy; Pamela Brewster | Zendy; David J. Kennedy | Zendy; Mark W. Burket | Zendy; William R. Colyer | Zendy; Haifeng Yu | Zendy; Dong Zhang | Zendy; Joseph I. Shapiro | Zendy; Christopher J. Cooper | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Platelet Activation in Patients with Atherosclerotic Renal Artery Stenosis Undergoing Stent Revascularization

Author(s) -

Steven T. Haller,

Satjit Adlakha,

Grant W. Reed,

Pamela Brewster,

David J. Kennedy,

Mark W. Burket,

William R. Colyer,

Haifeng Yu,

Dong Zhang,

Joseph I. Shapiro,

Christopher J. Cooper

Publication year - 2011

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.03140411

Subject(s) - medicine , renal artery stenosis , cardiology , platelet activation , renal artery , abciximab , stenosis , stent , platelet , artery , renal artery obstruction , revascularization , kidney , myocardial infarction , percutaneous coronary intervention

Soluble CD40 ligand (sCD40L) is a marker of platelet activation; whether platelet activation occurs in the setting of renal artery stenosis and stenting is unknown. Additionally, the effect of embolic protection devices and glycoprotein IIb/IIIa inhibitors on platelet activation during renal artery intervention is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research